We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPG:NASDAQTPG Inc. Analysis

Data as of 2026-06-17 - not real-time

$44.64

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TPG’s share price is trading just below a clear resistance zone, with the 20‑day and 50‑day moving averages already beneath the current level, suggesting limited upside in the near term. Technical momentum appears mixed: the MACD histogram is positive and the MACD line sits above its signal, yet the overall trend is flagged as bearish and the RSI hovers in a neutral‑to‑slightly‑bullish range. Volatility is elevated, reflected by a 30‑day swing above thirty percent and a beta well above one, indicating the stock moves more sharply than the market. Fundamentally, the stock looks significantly overvalued with a trailing PE far above industry norms and a DCF fair‑value estimate well below the market price. Despite a robust dividend yield, the company carries a heavy debt load and recent revenue has contracted sharply, raising concerns about long‑term earnings stability. However, forward earnings estimates have improved, and analyst price targets imply a notable upside potential if the earnings turnaround materializes.
The dividend appears sustainable at present, given a very low payout ratio and ample operating cash flow, though free cash flow is currently nil and debt levels are high. The recent announcement of a preferred‑stock dividend adds a short‑term cash return for certain shareholders. Forward‑looking metrics, such as a more reasonable forward PE and positive earnings guidance, support a medium‑term upside thesis, while the high valuation and market sentiment (extreme greed) caution against aggressive short‑term positioning. Overall, the stock sits at a crossroads between short‑term technical resistance and a longer‑term earnings recovery narrative.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near resistance with limited upside
  • Mixed technical signals (bullish MACD vs bearish trend)
  • High volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Improving forward earnings estimates
  • Attractive dividend yield with low payout ratio
  • Analyst price targets indicating upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Sustained high valuation relative to fundamentals
  • Heavy debt burden and recent revenue decline
  • Potential for earnings recovery balanced by sector risk

Key Metrics & Analysis

Financial Health

Revenue Growth-56.80%
Profit Margin4.23%
P/E Ratio186.0
ROE10.76%
ROA3.16%
Debt/Equity82.45
P/B Ratio6.0
Op. Cash Flow$1.0B
Industry P/E17.1

Technical Analysis

TrendBearish
RSI59.5
Support$39.25
Resistance$45.31
MA 20$42.08
MA 50$42.56
MA 200$52.42
MACDBullish
VolumeStable
Fear & Greed Index92.13

Valuation

Fair Value$18.52
Target Price$56.00
Upside/Downside25.45%
GradeOvervalued
TypeBlend
Dividend Yield5.02%

Risk Assessment

Beta1.47
Volatility35.62%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.